Literature DB >> 26511494

CogState computerized memory tests in patients with brain metastases: secondary endpoint results of NRG Oncology RTOG 0933.

Chip Caine1,2, Snehal Deshmukh3, Vinai Gondi4,5, Minesh Mehta6, Wolfgang Tomé7, Benjamin W Corn8, Andrew Kanner8, Howard Rowley6, Vijayananda Kundapur9, Albert DeNittis10, Jeffrey Noah Greenspoon11, Andre A Konski12, Glenn S Bauman13, Adam Raben14, Wenyin Shi15, Merideth Wendland16, Lisa Kachnic17.   

Abstract

Whole brain radiotherapy (WBRT) is associated with memory dysfunction. As part of NRG Oncology RTOG 0933, a phase II study of WBRT for brain metastases that conformally avoided the hippocampal stem cell compartment (HA-WBRT), memory was assessed pre- and post-HA-WBRT using both traditional and computerized memory tests. We examined whether the computerized tests yielded similar findings and might serve as possible alternatives for assessment of memory in multi-institution clinical trials. Adult patients with brain metastases received HA-WBRT to 30 Gy in ten fractions and completed Hopkins Verbal Learning Test-Revised (HVLT-R), CogState International Shopping List Test (ISLT) and One Card Learning Test (OCLT), at baseline, 2 and 4 months. Tests' completion rates were 52-53 % at 2 months and 34-42 % at 4 months. All baseline correlations between HVLT-R and CogState tests were significant (p ≤ 0.003). At baseline, both CogState tests and one component of HVLT-R differentiated those who were alive at 6 months and those who had died (p ≤ 0.01). At 4 months, mean relative decline was 7.0 % for HVLT-R Delayed Recall and 18.0 % for ISLT Delayed Recall. OCLT showed an 8.0 % increase. A reliable change index found no significant changes from baseline to 2 and 4 months for ISLT Delayed Recall (z = -0.40, p = 0.34; z = -0.68, p = 0.25) or OCLT (z = 0.15, p = 0.56; z = 0.41, p = 0.66). Study findings support the possibility that hippocampal avoidance may be associated with preservation of memory test performance, and that these computerized tests also may be useful and valid memory assessments in multi-institution adult brain tumor trials.

Entities:  

Keywords:  HVLT-R; ISLT; NRG Oncology RTOG 0933; Neurocognitive; OCLT

Mesh:

Year:  2015        PMID: 26511494      PMCID: PMC4891977          DOI: 10.1007/s11060-015-1971-2

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  43 in total

1.  Intraindividual cognitive decline using a brief computerized cognitive screening test.

Authors:  David G Darby; Robert H Pietrzak; Julia Fredrickson; Michael Woodward; Lynette Moore; Amy Fredrickson; Jack Sach; Paul Maruff
Journal:  Alzheimers Dement       Date:  2012       Impact factor: 21.566

2.  Effects of emotion on item and source memory in young and older adults.

Authors:  Patrick S R Davidson; Craig P McFarland; Elizabeth L Glisky
Journal:  Cogn Affect Behav Neurosci       Date:  2006-12       Impact factor: 3.282

Review 3.  Computerized neurocognitive testing in the management of sport-related concussion: an update.

Authors:  Jacob E Resch; Michael A McCrea; C Munro Cullum
Journal:  Neuropsychol Rev       Date:  2013-12-04       Impact factor: 7.444

4.  Memory function before and after whole brain radiotherapy in patients with and without brain metastases.

Authors:  Grit Welzel; Katharina Fleckenstein; Jörg Schaefer; Brigitte Hermann; Uta Kraus-Tiefenbacher; Sabine K Mai; Frederik Wenz
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-04-28       Impact factor: 7.038

5.  A method for cross-cultural adaptation of a verbal memory assessment.

Authors:  Yen Ying Lim; Khic Houy Prang; Lucette Cysique; Robert H Pietrzak; Peter J Snyder; Paul Maruff
Journal:  Behav Res Methods       Date:  2009-11

6.  Three-month stability of the CogState brief battery in healthy older adults, mild cognitive impairment, and Alzheimer's disease: results from the Australian Imaging, Biomarkers, and Lifestyle-rate of change substudy (AIBL-ROCS).

Authors:  Yen Ying Lim; Judith Jaeger; Karra Harrington; Tim Ashwood; Kathryn A Ellis; Albrecht Stöffler; Cassandra Szoeke; Rebecca Lachovitzki; Ralph N Martins; Victor L Villemagne; Ashley Bush; Colin L Masters; Christopher C Rowe; David Ames; David Darby; Paul Maruff
Journal:  Arch Clin Neuropsychol       Date:  2013-04-03       Impact factor: 2.813

7.  Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial.

Authors:  Christina A Meyers; Jennifer A Smith; Andrea Bezjak; Minesh P Mehta; James Liebmann; Tim Illidge; Ian Kunkler; Jean-Michel Caudrelier; Peter D Eisenberg; Jacobus Meerwaldt; Ross Siemers; Christian Carrie; Laurie E Gaspar; Walter Curran; See-Chun Phan; Richard A Miller; Markus F Renschler
Journal:  J Clin Oncol       Date:  2004-01-01       Impact factor: 44.544

8.  Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases.

Authors:  Minesh P Mehta; Patrick Rodrigus; C H J Terhaard; Aroor Rao; John Suh; Wilson Roa; Luis Souhami; Andrea Bezjak; Mark Leibenhaut; Ritsuko Komaki; Christopher Schultz; Robert Timmerman; Walter Curran; Jennifer Smith; See-Chun Phan; Richard A Miller; Markus F Renschler
Journal:  J Clin Oncol       Date:  2003-07-01       Impact factor: 44.544

9.  Computerized cognition assessment during acetylcholinesterase inhibitor treatment in Alzheimer's disease.

Authors:  K Wesnes; C Edgar; N Andreasen; P Annas; H Basun; L Lannfelt; H Zetterberg; K Blennow; L Minthon
Journal:  Acta Neurol Scand       Date:  2009-12-28       Impact factor: 3.209

10.  Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.

Authors:  Eric L Chang; Jeffrey S Wefel; Kenneth R Hess; Pamela K Allen; Frederick F Lang; David G Kornguth; Rebecca B Arbuckle; J Michael Swint; Almon S Shiu; Moshe H Maor; Christina A Meyers
Journal:  Lancet Oncol       Date:  2009-10-02       Impact factor: 41.316

View more
  12 in total

1.  Convergent and criterion validity of the CogState computerized brief battery cognitive assessment in women with and without breast cancer.

Authors:  Sunita K Patel; Adrienne M Meier; Nathaniel Fernandez; Tracy T Y Lo; Colleen Moore; Nicole Delgado
Journal:  Clin Neuropsychol       Date:  2017-01-12       Impact factor: 3.535

2.  Temozolomide in secondary prevention of HER2-positive breast cancer brain metastases.

Authors:  Alexandra S Zimmer; Seth M Steinberg; Dee Dee Smart; Mark R Gilbert; Terri S Armstrong; Eric Burton; Nicole Houston; Nadia Biassou; Brunilde Gril; Priscilla K Brastianos; Scott Carter; David Lyden; Stanley Lipkowitz; Patricia S Steeg
Journal:  Future Oncol       Date:  2020-04-09       Impact factor: 3.404

3.  A precision 3D conformal treatment technique in rats: Application to whole-brain radiotherapy with hippocampal avoidance.

Authors:  Suk W Yoon; Christina K Cramer; Devin A Miles; Michael H Reinsvold; Kyeung M Joo; David G Kirsch; Mark Oldham
Journal:  Med Phys       Date:  2017-09-30       Impact factor: 4.071

4.  The Impact of Stereotactic or Whole Brain Radiotherapy on Neurocognitive Functioning in Adult Patients with Brain Metastases: A Systematic Review and Meta-Analysis.

Authors:  Eva Elisabeth van Grinsven; Steven H J Nagtegaal; Joost J C Verhoeff; Martine J E van Zandvoort
Journal:  Oncol Res Treat       Date:  2021-09-03       Impact factor: 2.825

5.  Plan Quality Comparison Between Hippocampus-Sparing Whole-Brain Radiotherapy Treated With Halcyon and Tomotherapy Intensity-Modulated Radiotherapy.

Authors:  Kazutoshi Yokoyama; Hiromasa Kurosaki; Hajime Oyoshi; Kosei Miura; Nobuko Utsumi
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

6.  Neurocognitive evaluation of brain metastases patients treated with post-resection stereotactic radiosurgery: a prospective single arm clinical trial.

Authors:  Assaf Berger; Ido Strauss; Shlomit Ben Moshe; Benjamin W Corn; Dror Limon; Nathan Shtraus; Tal Shahar; Andrew A Kanner
Journal:  J Neurooncol       Date:  2018-08-04       Impact factor: 4.130

Review 7.  Neuro-Oncology Practice Clinical Debate: stereotactic radiosurgery or fractionated stereotactic radiotherapy following surgical resection for brain metastasis.

Authors:  Joshua D Palmer; Jeffrey Greenspoon; Paul D Brown; Derek R Johnson; David Roberge
Journal:  Neurooncol Pract       Date:  2019-10-01

8.  Preliminary exploration of a computerized cognitive battery and comparison with traditional testing in patients with high-grade glioma.

Authors:  Jane H Cerhan; Chip Caine; S Keith Anderson; Derek R Johnson; Daniel H Lachance; Elizabeth Yan; Paul D Brown
Journal:  Neurooncol Pract       Date:  2018-05-21

Review 9.  The impact of epidermal growth factor receptor mutations on patterns of disease recurrence after chemoradiotherapy for locally advanced non-small cell lung cancer: a literature review and pooled analysis.

Authors:  Satoru Ochiai; Yoshihito Nomoto; Yui Watanabe; Yasufumi Yamashita; Yutaka Toyomasu; Tomoko Kawamura; Akinori Takada; Hajime Sakuma
Journal:  J Radiat Res       Date:  2016-08-16       Impact factor: 2.724

10.  Influence of Modulation Factor on Treatment Plan Quality and Irradiation Time in Hippocampus-Sparing Whole-Brain Radiotherapy Using Tomotherapy.

Authors:  Akihiko Ishibashi; Hiromasa Kurosaki; Kosei Miura; Nobuko Utsumi; Hideyuki Sakurai
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.